Canada markets open in 17 minutes

Kezar Life Sciences, Inc. (2KZ.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.7250-0.0150 (-2.03%)
As of 08:01AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 56.97M
Enterprise Value -113.43M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.21
Price/Book (mrq)0.31
Enterprise Value/Revenue -16.20
Enterprise Value/EBITDA 1.14

Trading Information

Stock Price History

Beta (5Y Monthly) 0.46
52-Week Change 3-66.36%
S&P500 52-Week Change 324.19%
52 Week High 32.8000
52 Week Low 30.6150
50-Day Moving Average 30.7759
200-Day Moving Average 30.9377

Share Statistics

Avg Vol (3 month) 31.97k
Avg Vol (10 day) 322
Shares Outstanding 572.8M
Implied Shares Outstanding 676.99M
Float 852.48M
% Held by Insiders 114.81%
% Held by Institutions 167.92%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,503.39%

Management Effectiveness

Return on Assets (ttm)-25.26%
Return on Equity (ttm)-44.54%

Income Statement

Revenue (ttm)7M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -104.17M
Net Income Avi to Common (ttm)-101.87M
Diluted EPS (ttm)-1.3100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)201.37M
Total Cash Per Share (mrq)2.77
Total Debt (mrq)18.93M
Total Debt/Equity (mrq)10.09%
Current Ratio (mrq)11.66
Book Value Per Share (mrq)2.58

Cash Flow Statement

Operating Cash Flow (ttm)-81.64M
Levered Free Cash Flow (ttm)-39.23M